Cargando…

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study

BACKGROUND: Trivalent oral polio vaccine (tOPV) was replaced worldwide from April, 2016, by bivalent types 1 and 3 oral polio vaccine (bOPV) and one dose of inactivated polio vaccine (IPV) where available. The risk of transmission of type 2 poliovirus or Sabin 2 virus on re-introduction or resurgenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taniuchi, Mami, Famulare, Michael, Zaman, Khalequ, Uddin, Md Jashim, Upfill-Brown, Alexander M, Ahmed, Tahmina, Saha, Parimalendu, Haque, Rashidul, Bandyopadhyay, Ananda S, Modlin, John F, Platts-Mills, James A, Houpt, Eric R, Yunus, Mohammed, Petri, William A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science ;, The Lancet Pub. Group 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610141/ https://www.ncbi.nlm.nih.gov/pubmed/28693854 http://dx.doi.org/10.1016/S1473-3099(17)30358-4

Ejemplares similares

Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission
por: Famulare, Michael, et al.
Publicado: (2021)

The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks
por: Valesano, Andrew L., et al.
Publicado: (2021)

Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants
por: Upfill-Brown, Alexander, et al.
Publicado: (2017)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants
por: Taniuchi, Mami, et al.
Publicado: (2016)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Evaluation of Two New Membrane-Based and Microtiter Plate Enzyme-Linked Immunosorbent Assays for Detection of Campylobacter jejuni in Stools of Bangladeshi Children
por: Schnee, Amanda E., et al.
Publicado: (2018)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Identification of Etiology-Specific Diarrhea Associated With Linear Growth Faltering in Bangladeshi Infants
por: Schnee, Amanda E, et al.
Publicado: (2018)

Environmental Surveillance of Polioviruses in Armenia, Colombia before Trivalent Oral Polio Vaccine Cessation
por: González, María Mercedes, et al.
Publicado: (2019)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Association between enteropathogens and malnutrition in children aged 6–23 mo in Bangladesh: a case-control study(1)(2)(3)
por: Platts-Mills, James A, et al.
Publicado: (2017)

Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
por: Hassan, Joanne, et al.
Publicado: (2017)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia
por: Holmes, Marionette, et al.
Publicado: (2017)

A 10-Year Immunopersistence Study of Hepatitis E Antibodies in Rural Bangladesh
por: Kmush, Brittany L, et al.
Publicado: (2018)

Circulating Vaccine Derived Poliovirus and the polio eradication endgame
por: Davis, Robert, et al.
Publicado: (2012)

Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame
por: Thompson, Kimberly M., et al.
Publicado: (2020)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2019)

Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013–2016
Publicado: (2015)

Has Wild Poliovirus Been Eliminated from Nigeria?
por: Famulare, Michael
Publicado: (2015)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax®, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine
por: Sáez-Llorens, Xavier, et al.
Publicado: (2022)

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
por: Cooper, Laura V, et al.
Publicado: (2022)

Evaluation of Molecular Serotyping Assays for Shigella flexneri Directly on Stool Samples
por: Liu, Jie, et al.
Publicado: (2021)

Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
por: Famulare, Michael, et al.
Publicado: (2018)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
por: Abd-Elghaffar, Asmaa A., et al.
Publicado: (2020)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
por: Bahl, Sunil, et al.
Publicado: (2017)

Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Safeguarding vaccine production and supply strategies for polio eradication endgame
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2021)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Assessing the Risks for Poliovirus Outbreaks in Polio-Free Countries — Africa, 2012–2013
Publicado: (2013)

Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication
por: Aghamohammadi, Asghar, et al.
Publicado: (2017)

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
por: Ming, Long Chiau, et al.
Publicado: (2020)

The resurgence of wild poliovirus in Pakistan and Afghanistan: A new setback for polio eradication
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vv2p9vfei3113nmv7ba826g002